Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Mol Imaging. 2008 JUL-AUG;7(4):187–197.

Figure 5.

Figure 5

(A). Co-registered SPECT/CT images in a CD1 mouse after [125I]IBDG administration to control D54 tumors (left flank) and β-gal-expressing D54L tumors (right flank). (B). Time-radioactivity curves of administered [125I]IBDG in mouse D54 and D54L tumors.